Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media

Endocrinology

Volumn 145, Issue 12, 2004, Pages 5638-5645

  Yasuzawa Amano, Saori ^a   Toyoda, Nagaoki ^a   Maeda, Akimasa ^a   Kosaki, Atsushi ^a   Mori, Yasukiyo ^a   Iwasaka, Toshiji ^a   Nishikawa, Mitsushige ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IODOTHYRONINE DEIODINASE 2; ISOPRENALINE; MESSENGER RNA; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BETA ADRENERGIC STIMULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; EUTHYROIDISM; GENE EXPRESSION REGULATION; HYPOTHYROIDISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; PRAZOSIN; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; THYROXINE; TRIIODOTHYRONINE; TUNICA MEDIA; YOHIMBINE;

EID: 9444230628     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0632     Document Type: Article

References (33)

1. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
2. Leonard JL, Visser TJ 1986 Biochemistry of demodulation. In: Henneman G, ed. Thyroid hormone metabolism. New York: Marcel Dekker; 189-229
3. Croteau W, Davey JC, Gallon VA, St Germain DL 1996 Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405-417
4. Salvatore D, Bartha T, Harney JW, Larsen PR 1996 Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308-3315
5. Salvatore D, Tu H, Harney JW, Larsen PR 1996 Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968
6. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, Mori M 1999 Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab 84:3293-3300
7. Imai Y, Toyoda N, Maeda A, Kadobayashi T, Wang F, Kuma K, Nishikawa M, Iwasaka T 2001 Type 2 iodothyronine deiodinase expression is upregulated by the PKA-dependent pathway and is downregulated by the PKC-dependent pathway in cultured human thyroid cells. Thyroid 11:899-907
8. 4. Mol Endocrinol 15:2137-2148
9. De Jesus LA, Cavalho SD, Ribeiro MO, Schneider M, Kim S-W, Harney JW, Larsen PR, Bianco AC 2001 The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108:1379-1385
10. Mizuma H, Murakami M, Mori M 2001 Thyroid hormone activation in human vascular smooth muscle cells. Circ Res 88:313-318
11. Maeda A, Toyoda N, Yasurawa-Amano S, Iwasaka T, Nishikawa M 2003 Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells. Mol Cell Endocrinol 200:111-117
12. Silva JE, Larsen PR 1983 Adrenergic activation of triiodothyronine production in brown adipose tissue. Nature 305:712-713
13. Tanaka K, Murakami M, Greer MA 1987 Rhythmicity of triiodothyronine generation by type II thyroxine 5′-deiodinase in rat pineal is mediated by a β-adrenergic mechanism. Endocrinology 121:74-77
14. Osuna C, Jimenez J, Reiter RJ, Rubio A, Guerrero JM 1992 Adrenergic regulation of type II 5′-deiodinase circadian rhythm in rat harderian gland. Am J Physiol 263:E884-E889
15. Murakami M, Greer MA, Hjulstad S, Greet SE, Tanaka K 1989 Evidence that rat pineal thyroxine 5′-deiodinase is primarily stimulated by β- and not α-adrenergic agonists and that its adrenergic-stimulated and spontaneous rhythmic nocturnal rise require RNA and protein synthesis. Proc Soc Exp Biol Med 190:190-194
16. Kamiya Y, Murakami M, Araki O, Hosoi Y, Ogiwara T, Mizuma H, Mori M 1999 Pretranslational regulation of rhythmic type II iodothyronine deiodinase expression by β-adrenergic mechanism in the rat pineal gland. Endocrinology 140:1272-1278
17. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
18. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
19. Sancher-Carbayo M, Mauri M, Alfayate R, Miralles C, Soria F 1999 Analytical and clinical evaluation of TSH and thyroid hormones by electrochemiluminescent immunoassays. Clin Biochem 32:395-403
20. Campos-Bartos A, Musa A, Flechner A, Hessenius C, Gaio U, Meinhold H, Baumgartner A 1997 Evidence for circadian variations of thyroid hormone concentrations and type II 5′-iodothyronine deiodinase activity in the rat central nervous system. J Neurochem 68:795-803
21. Raasmaja A, Larsen PR 1989 α1- and β-adrenergic agents cause synergistic stimulation of the iodothyronine deiodinase in rat brown adipocytes. Endocrinology 125:2502-2509
22. Araki O, Murakami M, Kamiya Y, Hosoi Y, Ogiwara T, Mizuma H, Iriuchijima T, Mori M 1998 Northern analysis of type II iodothyronine deiodinase mRNA in rat Harderian gland. Life Sci 63:1843-1848
23. Sudo A 1989 Circadian variation in urinary adrenaline levels in the rat after swimming exposure. Ind Health 27:135-139
24. Westerink BHC, Koolstra W 1986 Circadian variation of catecholamine excretion in rats: correlation with locomotor activity and effects of drugs. Neuropharmacology 25:1255-1262
25. Burmeister LA, Pachucki J, St Germain DL 1997 Thyoid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138:5231-5237
26. Kim SW, Harney JW, Larsen PR 1998 Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139:4895-4905
27. Leonard JL, Suva JE, Kaplan MM, Mellen SA, Visser TJ, Larsen PR 1984 Acute post-transcriptional regulation of cerebrocortical and pituitary iodothyronine 5′-deiodinases by thyroid hormone. Endocrinology 114:998-1004
28. Steinsapir J, Harney JW, Larsen PR 1998 Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes. J Clin Invest 102:1895-1899
29. Steinsapir J, Bianco AC, Buettner C, Harney JW, Larsen PR 2000 Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. Endocrinology 141:1127-1135
30. Gereben B, Goncalves C, Harney JW, Larsen PR, Bianco AC 2000 Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol Endocrinol 14: 1697-1708
31. Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW 1997 The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg 85:734-738
32. Ojamaa K, Klemperer JD, Klein I 1996 Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505-512
33. Zhang B, Sannajust F 2000 Diurnal rhythms of blood pressure, heart rate, and locomotor activity in adult and old male Wistar rats. Physiol Behav 70:375-380